Kase, Hiroshi <br/><br/>
Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease.  [electronic resource] 

 -  Neurology  Dec 2003 
 - S97-100 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1526-632X 
<br/><br/><label>Standard No.: </label>10.1212/01.wnl.0000095219.22086.31  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine A2 Receptor Antagonists<br/>Animals<br/>Antiparkinson Agents--adverse effects<br/>Clinical Trials as Topic--statistics & numerical data<br/>Corpus Striatum--cytology<br/>Disease Models, Animal<br/>Drug Evaluation, Preclinical<br/>Dyskinesia, Drug-Induced--prevention & control<br/>Globus Pallidus--cytology<br/>Humans<br/>Levodopa--adverse effects<br/>Mice<br/>Mice, Knockout<br/>Motor Activity--drug effects<br/>Neurons--drug effects<br/>Oxidopamine<br/>Parkinson Disease--drug therapy<br/>Parkinsonian Disorders--chemically induced<br/>Primates<br/>Purines--therapeutic use<br/>Rats<br/>Receptor, Adenosine A2A--metabolism<br/>Receptors, Dopamine D2--deficiency<br/>gamma-Aminobutyric Acid--metabolism